Use of a 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-κB
ES2197003A1
NEW ANTAGONIST COMPOUNDS OF INTEGRINAS ALFA.
ES2190373A1
USE OF 2-HYDROXY- OR 2-ACETILOXI-4-TRIFLUOROMETILBENZOIC ACID AS AN AGENT FOR THE TREATMENT AND PREVENTION OF LIGHT COGNITIVE DETERIORATION.
ES2184633A1
PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 4- (IMIDAZOL-1-IL) BENCENOSULFONAMIDE.
US6653475B2
Method for preparing pyrimidone derivatives with antifungal activity
ES2166710A1
NEW HETEROCICLIC COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY.
ES2159489A1
New imidazol derivatives with anti-inflammatory activity.
WO0023426A1
Novel imidazoles with anti-inflammatory activity
ES2154242A1
NEW BIOCOMPATIBLE POLYMERIC SYSTEMS CARRIERS OF TRIFLUSAL OR HTB.
AU2151399A
Novel piperidines and piperazines as platelet aggregation inhibitors
ES2136581A1
Use of derivatives of acid-2-hidroxi-4-trifluorometilbenzoico for the preparation of useful medicines to inhibit the nuclear transcription factor nf-kb.
WO9846599A1
Novel carboxamides as platelet aggregation inhibitors
ES2133090A1
New applicator for the administration of semi-solid medications.
ES2120899A1
Procedure for the preparation of 8-chloro-6, 11-dihydro-11- (1- (5-methyl-3-piridinyl) methyl) -4-piperidinylidene) -5h-benzo (5,6) cyclohepta (1, 2-b) piridine.
CA2204747A1
New azo derivatives of 5-aminosalicylic acid
WO9705130A1
New pyrimidone derivatives with antifungal activity
